These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10412677)

  • 21. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
    Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
    Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study.
    Olaguibel JM; Tabar AI; García Figueroa BE; Cortés C
    Allergy; 1997 Feb; 52(2):168-78. PubMed ID: 9105521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
    Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
    Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study.
    Tabar AI; Fernández-Távora L; Alonso R; Castillo R; Cisteró-Bahima A; de la Torre-Morin F; Fernández J; García-Figueroa BE; Fernández S; García-González JJ; García-Robaina JC; Moreno F; Lobatón P; Sánchez-Machín I; de la Torre-Martínez F
    J Investig Allergol Clin Immunol; 2004; 14(3):193-7. PubMed ID: 15552712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
    Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
    Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
    Cantani A; Ragno V; Monteleone MA; Lucenti P; Businco L
    J Investig Allergol Clin Immunol; 1996; 6(4):270-6. PubMed ID: 8844506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of sublingual immunotherapy in Asian children.
    Park IH; Hong SM; Lee HM
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
    Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Accelerated desensitization to Dermatophagoides pteronyssinus mites in children with asthma. Results of two years of immunotherapy].
    Le Roux P; Le Luyer B
    Allerg Immunol (Paris); 1991 Apr; 23(4):135-42. PubMed ID: 2069687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.
    Bousquet J; Hejjaoui A; Clauzel AM; Guérin B; Dhivert H; Skassa-Brociek W; Michel FB
    J Allergy Clin Immunol; 1988 Dec; 82(6):971-7. PubMed ID: 3204255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study.
    Tari MG; Mancino M; Monti G
    J Investig Allergol Clin Immunol; 1992; 2(2):59-67. PubMed ID: 1342886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once daily sublingual immunotherapy without updosing--A new treatment schedule.
    Rodriguez F; Boquete M; Ibáñez MD; de la Torre-Martínez F; Tabar AI
    Int Arch Allergy Immunol; 2006; 140(4):321-6. PubMed ID: 16741368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.